Gustavo Grampp

684 total citations
24 papers, 506 citations indexed

About

Gustavo Grampp is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Gustavo Grampp has authored 24 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Gustavo Grampp's work include Biosimilars and Bioanalytical Methods (13 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers) and Protein purification and stability (6 papers). Gustavo Grampp is often cited by papers focused on Biosimilars and Bioanalytical Methods (13 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers) and Protein purification and stability (6 papers). Gustavo Grampp collaborates with scholars based in United States, Switzerland and Japan. Gustavo Grampp's co-authors include Jason B. Litten, Gary N. Rogers, Robert I. Scheinman, Carrie Brown, Kenneth Getz, Stella Stergiopoulos, Esther Choi, Pamela S. Hunt, Hideya Ohashi and Janice Chen and has published in prestigious journals such as Annals of the New York Academy of Sciences, Stem Cells and Journal of Pharmaceutical Sciences.

In The Last Decade

Gustavo Grampp

23 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gustavo Grampp United States 11 235 167 122 112 86 24 506
Hans C. Ebbers Netherlands 14 514 2.2× 60 0.4× 89 0.7× 288 2.6× 52 0.6× 31 645
Talia M. Muram United States 11 775 3.3× 51 0.3× 34 0.3× 89 0.8× 116 1.3× 18 972
Michael Muenzberg United States 10 357 1.5× 20 0.1× 40 0.3× 191 1.7× 64 0.7× 16 516
Carolyn R. Lew United States 14 96 0.4× 162 1.0× 9 0.1× 22 0.2× 37 0.4× 29 471
Laura Longo Italy 10 31 0.1× 44 0.3× 57 0.5× 94 0.8× 49 0.6× 27 377
Kinjal Sanghavi United States 11 111 0.5× 70 0.4× 35 0.3× 11 0.1× 34 0.4× 24 526
Shanthi Sivendran United States 11 40 0.2× 94 0.6× 11 0.1× 41 0.4× 19 0.2× 28 410
Nathalie Letarte Canada 10 52 0.2× 137 0.8× 15 0.1× 26 0.2× 17 0.2× 26 477
Sigrid Balser United States 10 125 0.5× 44 0.3× 21 0.2× 31 0.3× 52 0.6× 15 303
Kurt R. Oettel United States 10 95 0.4× 150 0.9× 30 0.2× 6 0.1× 41 0.5× 25 545

Countries citing papers authored by Gustavo Grampp

Since Specialization
Citations

This map shows the geographic impact of Gustavo Grampp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustavo Grampp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustavo Grampp more than expected).

Fields of papers citing papers by Gustavo Grampp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gustavo Grampp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustavo Grampp. The network helps show where Gustavo Grampp may publish in the future.

Co-authorship network of co-authors of Gustavo Grampp

This figure shows the co-authorship network connecting the top 25 collaborators of Gustavo Grampp. A scholar is included among the top collaborators of Gustavo Grampp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustavo Grampp. Gustavo Grampp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grampp, Gustavo, et al.. (2023). Managing integrated continuous bioprocesses in real time: Deviations in product quality. Biotechnology Progress. 40(2). e3414–e3414. 1 indexed citations
2.
Thorpe, Robin, Gustavo Grampp, Hye‐Na Kang, & Ivana Knežević. (2019). Quality assessment and its impact on clinical performance of a biosimilar erythropoietin: A simulated case study. Biologicals. 62. 8–15. 4 indexed citations
3.
4.
Stergiopoulos, Stella, et al.. (2016). A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals. Drug Safety. 39(11). 1117–1127. 43 indexed citations
5.
Grampp, Gustavo, et al.. (2016). Policy considerations for originator and similar biotherapeutic products. Pharmaceuticals Policy and Law. 18(1-4). 121–139. 1 indexed citations
6.
Grampp, Gustavo, et al.. (2015). The Diversity of Biosimilar Design and Development: Implications for Policies and Stakeholders. BioDrugs. 29(6). 365–372. 23 indexed citations
7.
Stergiopoulos, Stella, et al.. (2015). Identifying and Quantifying the Accuracy of Product Name Attribution of US-Sourced Adverse Event Reports in MedWatch of Somatropins and Insulins. Therapeutic Innovation & Regulatory Science. 49(5). 706–716. 6 indexed citations
8.
Grampp, Gustavo, et al.. (2015). Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars. Expert Opinion on Drug Safety. 14(3). 349–360. 12 indexed citations
9.
Grampp, Gustavo, et al.. (2015). Pharmacovigilance Considerations for Biosimilars in the USA. BioDrugs. 29(5). 309–321. 23 indexed citations
10.
Grampp, Gustavo, et al.. (2014). Drift, Evolution, and Divergence in Biologics and Biosimilars Manufacturing. BioDrugs. 28(4). 363–372. 73 indexed citations
11.
Grampp, Gustavo, et al.. (2014). Preventing shortages of biologic medicines. Expert Review of Clinical Pharmacology. 7(2). 151–159. 3 indexed citations
12.
Grampp, Gustavo, et al.. (2013). Managing Unexpected Events in the Manufacturing of Biologic Medicines. BioDrugs. 27(4). 305–316. 14 indexed citations
13.
Miletich, Joseph P., et al.. (2011). Biosimilars 2.0. mAbs. 3(3). 318–325. 14 indexed citations
14.
Mounho, Barbara, et al.. (2010). Global regulatory standards for the approval of biosimilars.. PubMed. 65(4). 819–37, ii. 5 indexed citations
15.
Qin, Qiang, et al.. (2007). Sodium butyrate alters erythropoietin glycosylation via multiple mechanisms. Biotechnology and Bioengineering. 99(1). 201–213. 21 indexed citations
16.
Grampp, Gustavo, et al.. (2006). Amino acid and manganese supplementation modulates the glycosylation state of erythropoietin in a CHO culture system. Biotechnology and Bioengineering. 96(3). 538–549. 88 indexed citations
17.
Grampp, Gustavo, Athanassios Sambanis, & Gregory Stephanopoulos. (2005). Use of regulated secretion in protein production from animal cells: An overview. Advances in biochemical engineering, biotechnology. 46. 35–62.
18.
Grampp, Gustavo, Harvey F. Lodish, & Gregory Stephanopoulos. (1997). Analysis of secretory dynamics and development of media for the controlled secretion of insulin-related peptides from βTC-3 insulinoma cells. Biotechnology and Bioengineering. 53(3). 274–282. 1 indexed citations
19.
Grampp, Gustavo, Harvey F. Lodish, & Gregory Stephanopoulos. (1997). Processing and secretion of insulin-related peptides in an insulinoma cell line. Biotechnology and Bioengineering. 53(3). 283–289. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans C. Ebbers Breakdown of academic impact, for papers by Talia M. Muram Breakdown of academic impact, for papers by Michael Muenzberg Breakdown of academic impact, for papers by Carolyn R. Lew Breakdown of academic impact, for papers by Laura Longo Breakdown of academic impact, for papers by Kinjal Sanghavi Breakdown of academic impact, for papers by Shanthi Sivendran Breakdown of academic impact, for papers by Nathalie Letarte Breakdown of academic impact, for papers by Sigrid Balser Breakdown of academic impact, for papers by Kurt R. Oettel
Rankless by CCL
2026